These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12433441)

  • 1. Biodegradable poly(epsilon -caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen.
    Chawla JS; Amiji MM
    Int J Pharm; 2002 Dec; 249(1-2):127-38. PubMed ID: 12433441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular uptake and concentrations of tamoxifen upon administration in poly(epsilon-caprolactone) nanoparticles.
    Chawla JS; Amiji MM
    AAPS PharmSci; 2003; 5(1):E3. PubMed ID: 12713275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer.
    Shenoy DB; Amiji MM
    Int J Pharm; 2005 Apr; 293(1-2):261-70. PubMed ID: 15778064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery.
    Potineni A; Lynn DM; Langer R; Amiji MM
    J Control Release; 2003 Jan; 86(2-3):223-34. PubMed ID: 12526819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of in vitro parameters of tamoxifen citrate loaded poly(lactide-co-glycolide), poly(epsilon-caprolactone) and chitosan nanoparticles.
    Cirpanli Y; Yerlikaya F; Ozturk K; Erdogar N; Launay M; Gegu C; Leturgez T; Bilensoy E; Calis S; Capan Y
    Pharmazie; 2010 Dec; 65(12):867-70. PubMed ID: 21284254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery.
    Kaul G; Amiji M
    Pharm Res; 2002 Jul; 19(7):1061-7. PubMed ID: 12180540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained antibacterial activity of doxycycline-loaded poly(D,L-lactide-co-glycolide) and poly(epsilon-caprolactone) nanoparticles.
    Misra R; Acharya S; Dilnawaz F; Sahoo SK
    Nanomedicine (Lond); 2009 Jul; 4(5):519-30. PubMed ID: 19572818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations.
    Shenoy D; Little S; Langer R; Amiji M
    Mol Pharm; 2005; 2(5):357-66. PubMed ID: 16196488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles.
    Devalapally H; Duan Z; Seiden MV; Amiji MM
    Clin Cancer Res; 2008 May; 14(10):3193-203. PubMed ID: 18483388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen citrate-loaded poly(d,l) lactic acid nanoparticles: Evaluation for their anticancer activity in vitro and in vivo.
    Ravikumara NR; Bharadwaj M; Madhusudhan B
    J Biomater Appl; 2016 Nov; 31(5):755-772. PubMed ID: 27664187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective cellular internalization, cell cycle arrest and improved pharmacokinetics of Tamoxifen by cholesterol based lipopolymeric nanoparticles.
    Mazumdar S; Italiya KS; Sharma S; Chitkara D; Mittal A
    Int J Pharm; 2018 May; 543(1-2):96-106. PubMed ID: 29578081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model.
    Devalapally H; Shenoy D; Little S; Langer R; Amiji M
    Cancer Chemother Pharmacol; 2007 Mar; 59(4):477-84. PubMed ID: 16862429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular delivery of saquinavir in biodegradable polymeric nanoparticles for HIV/AIDS.
    Shah LK; Amiji MM
    Pharm Res; 2006 Nov; 23(11):2638-45. PubMed ID: 16969696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen-loaded nanoparticles based on a novel mixture of biodegradable polyesters: characterization and in vitro evaluation as sustained release systems.
    Pérez E; Benito M; Teijón C; Olmo R; Teijón JM; Blanco MD
    J Microencapsul; 2012; 29(4):309-22. PubMed ID: 22251238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
    Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
    J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.
    Alex AT; Joseph A; Shavi G; Rao JV; Udupa N
    Drug Deliv; 2016 Sep; 23(7):2144-2153. PubMed ID: 25544603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies.
    Mundargi RC; Srirangarajan S; Agnihotri SA; Patil SA; Ravindra S; Setty SB; Aminabhavi TM
    J Control Release; 2007 May; 119(1):59-68. PubMed ID: 17331611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of particle morphology of pH-dependent poly(epsilon-caprolactone)-poly(gamma-glutamic acid) micellar nanoparticles to combat breast cancer cells.
    Chan AS; Chen CH; Huang CM; Hsieh MF
    J Nanosci Nanotechnol; 2010 Oct; 10(10):6283-97. PubMed ID: 21137721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and evaluation of D-α tocopheryl polyethylene glycol 1000 succinate emulsified poly-ϵ-caprolactone nanoparticles for protein/peptide drug delivery.
    Rayaprolu BM; Strom JG
    Drug Dev Ind Pharm; 2013 Jul; 39(7):1046-52. PubMed ID: 22758209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
    Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
    Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.